Medications for Hepatorenal Syndrome
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatorenal Syndrome.
Found 1 Approved Drug for Hepatorenal Syndrome
Terlivaz
Generic Name
Terlipressin
Terlivaz
Generic Name
Terlipressin
Form: Injection
Method of administration: Intravenous
FDA approval date: September 14, 2022
Classification: Vasopressin Receptor Agonist
TERLIVAZ is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. TERLIVAZ is a vasopressin receptor agonist indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. ( 1 ) Limitation of Use Patients with a serum creatinine >5 mg/dL are unlikely to experience benefit. ( 1 ) Limitation of Use Patients with a serum creatinine > 5 mg/dL are unlikely to experience benefit.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances